Chemed Corporation (NYSE:CHE - Get Free Report) EVP Spencer Lee sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the sale, the executive vice president owned 13,912 shares of the company's stock, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Chemed Trading Down 0.1%
NYSE:CHE opened at $540.18 on Tuesday. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The firm's 50 day moving average is $501.57 and its 200 day moving average is $447.26. The stock has a market capitalization of $7.06 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51.
Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the prior year, the company earned $4.27 earnings per share. Chemed's revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.
Chemed Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a $0.70 dividend. This is an increase from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed's payout ratio is 14.06%.
Institutional Trading of Chemed
Institutional investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System boosted its stake in Chemed by 45,134.8% in the 2nd quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company's stock worth $3,546,106,000 after purchasing an additional 7,597,086 shares during the period. HB Wealth Management LLC bought a new stake in shares of Chemed during the second quarter valued at about $542,000. Compass Financial Management LLC bought a new stake in shares of Chemed during the second quarter valued at about $52,000. Syon Capital LLC purchased a new stake in shares of Chemed in the second quarter worth about $235,000. Finally, denkapparat Operations GmbH purchased a new stake in shares of Chemed in the second quarter worth about $638,000. Hedge funds and other institutional investors own 95.85% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on CHE shares. Weiss Ratings upgraded Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Finally, Oppenheimer raised their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a report on Friday, July 31st. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $530.75.
Read Our Latest Research Report on CHE
Chemed Company Profile
(
Get Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
